Transitional Cell Carcinoma: Experimental - Coverage From The 60th Annual Congress Of The German Urological Association
Main Category: Urology / NephrologyAlso Included In: Cancer / Oncology
Article Date: 17 Oct 2008 - 2:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
STUTTGART, GERMANY (UroToday.com) - Apoptotic DNA fragments in serum of patients with muscle-invasive bladder cancer are of prognostic relevance.
The authors compared 45 patients with muscle-invasive bladder cancer and 45 patients with BPH. With the aim of RT-PCR, two DNA fragments were identified and found to be present in significantly higher levels in serum of patients with muscle-invasive bladder cancer compared to patients with BPH. Sensitivity was 96% and specificity 62%. Also, the apoptotic index was higher in patients with muscle-invasive bladder cancer. There was no correlation with tumor stage according to TNM.
The authors concluded that the presence of apoptotic DNA fragments in serum of patients with muscle-invasive bladder cancer is a negative prognostic phenomenon.
Abstract #P7.1
Presented by J. Ellinger, MD, et al., at the 60th Annual Congress of the German Urological Association (DGU) - September 24 - 27, 2008 - Stuttgart, Germany
Reported by Christian Doehn, MD, a Contributing Editor with UroToday.com
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/125810.php>
APA
http://www.medicalnewstoday.com/releases/125810.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



